Fujita Health University
Clinical trials sponsored by Fujita Health University, explained in plain language.
-
New drug combo aims to slow Parkinson's – safety trial begins
Disease control Recruiting nowThis early-stage trial tests the safety of combining two oral drugs, febuxostat and inosine, in 24 adults with early Parkinson's disease. Participants take the medication twice daily for 12 weeks while researchers monitor blood changes and side effects. The study does not promise…
Phase: PHASE1 • Sponsor: Fujita Health University • Aim: Disease control
Last updated May 17, 2026 17:25 UTC
-
Heart attack plaque study aims to sharpen diagnosis
Knowledge-focused Recruiting nowThis study looks at tissue removed from the blocked arteries of 200 people having a heart attack. Researchers want to see if images taken during the procedure match what they find under a microscope. The goal is to improve how doctors identify the type of plaque causing the heart…
Sponsor: Fujita Health University • Aim: Knowledge-focused
Last updated May 04, 2026 16:21 UTC